Currency In USD
| Previous Close | 10.49 |
| Open | 10.28 |
| Day High | 10.34 |
| Day Low | 10.1 |
| 52-Week High | 17.25 |
| 52-Week Low | 5.71 |
| Volume | 210,364 |
| Average Volume | 594,524 |
| Market Cap | 640.84M |
| PE | -8.68 |
| EPS | -1.18 |
| Moving Average 50 Days | 13.11 |
| Moving Average 200 Days | 12.13 |
| Change | -0.25 |
Design Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 26, 2025 1:00 PM GMT
CARLSBAD, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate i
Design Therapeutics Appoints Justin Gover to Board of Directors
GlobeNewswire Inc.
Sep 10, 2025 8:01 PM GMT
CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of industry veter
Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
GlobeNewswire Inc.
Aug 27, 2025 12:00 PM GMT
CARLSBAD, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate i